In today’s Bulldog Update of technology news: Best Buy survey cites best holiday tech gifts; making room for HQ Raleigh; cyber security bill advances in Senate, Quintiles, IMS Health form strategic alliance.

Best tech gifts

A national study commissioned by Best Buy identifies the tech gifts on 2015 holiday wish lists.

The top 15 are:

1. iPad
2. Bose QuietComfort 25 Noise Cancelling Headphones
3. MacBook
4. Samsung 48” Smart 4K Ultra HD TV
5. Sharp 43” Smart HDTV with Roku
6. Microsoft Surface
7. Bose SoundLink Mini Bluetooth Speaker II
8. Fitbit Charge HR Heart Rate and Activity Tracker
9. Samsung Galaxy Tab S2
10. Dyson V6 Absolute Bagless Cordless Vacuum
11. Vizio 43” Smart 4K Ultra HD TV
12. Apple Watch
13. SONOS PLAY:1 Wireless Speaker
14. iRobot Roomba Vacuum Cleaning Robot
15. GoPro HERO4 Action Camera

The study also found that millennials rank consumer electronics at the top of their gift wish lists, and not surprisingly, more men than women prefer to give and receive tech gifts. A whopping 85 percent of those surveyed said they take advantage of deals and discounts during the holidays.

Warehouse comes down next week at HQ Raleigh location

Next week the warehouse at 319 S. West St. in Raleigh will be demolished to make room for the 5-story startup hub, HQ Raleigh.

The space will be home to 350 companies.

At present, HQ Raleigh can host about 145 companies in 25,000 square feet of space in downtown Raleigh and like the American Underground Triangle facilities, has a waiting list of startups wanting offices.

For the full story see: The Triangle Business Journal’s report at http://www.bizjournals.com/triangle/blog/techflash/2015/10/demolition-starts-next-week-for-hq-raleighs-new-5.html

Cyber security bill advances in U.S. Senate

The long-delayed Cybersecurity Information Sharing Act (CISA) is being debated in the U.S. Senate and is likely to pass next week, reports say.

The controversial bill would grant legal immunity to companies who violate your privacy when sharing information.

The idea behind the bill is to encourage companies and the government to share information about cyber attacks in hopes of effectively combating them.

Privacy activists and some lawmakers, including GOP Senator Rand Paul and Democrat Ron Wyden, oppose it.

For the full story see: http://www.reuters.com/article/2015/10/22/us-usa-cybersecurity-congress-idUSKCN0SG24820151022

Quintiles, HMS Health form strategic alliance

Quintiles and IMS Health today announced a global strategic alliance that will advance the way biopharmaceutical companies generate real-world evidence (RWE) and apply critical insights to drive late-stage clinical research. With complementary strengths in real-world data management, operational delivery, advanced analytics, and scientific and therapeutic expertise, the collaboration will accelerate assessments of treatment impact and help improve patient outcomes.

As healthcare stakeholders increase their focus on value, evidence of a medicine’s effectiveness and safety in real-world settings continues to be a critical component of drug development and healthcare delivery. This alliance brings together market-leading capabilities in prospective and retrospective research, operational study delivery, proprietary RWE technologies and epidemiological expertise to provide customers with a complete view of a product’s impact and the patient experience in clinical practice.

“As demand increases for real-world evidence, biopharmaceutical companies need to integrate data from multiple sources to accelerate critical insights for stakeholders,” said Scott Evangelista, president, Integrated Healthcare Services at Quintiles. “This collaboration greatly enhances access to healthcare data from across the world – providing customers with the critical information and the related services needed to demonstrate the value of their medicines to physicians, payers and patients.”

The alliance will combine IMS Health’s strength in technology-enabled RWE information management, deep understanding of global health systems and advanced clinical and commercial analytics with Quintiles’ global breadth of operational expertise, experience in prospective studies and scientific knowledge to support all aspects of real-world and late-phase research.